berberine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“Furthermore, the FBG, RBG and TG in BBR- and HGSD-treated mice were significantly lower than those in db/db mice, and the OGTT and ITT were significantly improved compared with those in the db/db group.”
Quoted verbatim from Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA2β/Cardiolipin/Opa1 pathway in db/db mice and in Palmitate-treated MIN6 β-cells.. - Study
- animal · not in humans
- Dose
- berberine 160 mg/kg daily for 4 weeks
- Population
- Male db/db mice treated with berberine alone versus saline-treated db/db mice; the sentence pools berberine-treated and Huang-Gui Solid Dispersion-treated mice
Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA2β/Cardiolipin/Opa1 pathway in db/db mice and in Palmitate-treated MIN6 β-cells.2019PMID:31337982Permalink
Keep reading
- Everything the graph holds on berberine
- Every compound studied against Triglycerides
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45T4MWJZ82QAEZM8ENWH82K